After Q2 Significant Drop, Pfizer and Moderna COVID-19 Vaccine Revenues to…
Due to lowered global demand, for the first time, Pfizer/BioNTech and Moderna are expected to see sales revenues for their COVID-19 vaccines take a major fall in Q2, but sales…